Showing 1021-1030 of 19239 results for "".
Managing Adverse Events Associated With Menin Inhibitors
https://reachmd.com/programs/cme/managing-adverse-events-associated-with-menin-inhibitors/36182/Explore advances in AML that integrate risk stratification, molecular profiling, and menin-targeted therapies to optimize care and improve outcomes.How to Identify & Manage Patients with Progressive-Fibrosing ILD
https://reachmd.com/programs/cme/how-to-identify-and-manage-patients-with-progressive-fibrosing-ild/10942/ILD diagnosis is complex and management can be tricky. Hear how to navigate this path and how the patient’s perspective can influence the care plan.Future-Proofing in HAE: Advances in Long-term Prophylaxis to Prevent Attacks and Improve Quality of Life
https://reachmd.com/programs/cme/future-proofing-in-hae-advances-in-long-term-prophylaxis-to-prevent-attacks-and-improve-quality-of-life/54448/On-demand webcast with expert faculty presentation on addressing the unmet needs and optimizing treatment for hereditary angioedema (HAE), including long-term prophylaxis therapy, for patients with HAE.Bronchiectasis Update: Diagnostic Innovations and Therapeutic Frontiers
https://reachmd.com/programs/cme/bronchiectasis-update-diagnostic-innovations-and-therapeutic-frontiers/37233/Bronchiectasis is complex, often underdiagnosed, and frequently misunderstood. Explore key contributors to disease progression, including the role of neutrophilic inflammation and neutrophilic serine proteases, and learn to distinguish bronchiectasis from other respiratory conditions and assess patiBreaking the Cycle: Prioritizing Weight Loss to Improve OSA Management
https://reachmd.com/programs/cme/breaking-the-cycle-prioritizing-weight-loss-to-improve-osa-management/48715/On-demand webcast of expert faculty presentation on the connection between obstructive sleep apnea (OSA) and obesity, including strategies for prioritizing weight loss to improve OSA management among select patients.Hitting the Target in Atopic Dermatitis: Interdisciplinary Team Training for Leveraging IL-13 Inhibitors to Address the Burden of Disease
https://reachmd.com/programs/cme/hitting-the-target-in-atopic-dermatitis-interdisciplinary-team-training-for-leveraging-il-13-inhibitors-to-address-the-burden-of-disease/54437/On-demand webcast on the role of interleukin (IL)-13 in atopic dermatitis pathophysiology and strategies for leveraging IL-13 inhibitors to address disease burden and improve patient outcomes.Collaborative Care for CRSwNP Expert and Patient Insights
https://reachmd.com/programs/cme/collaborative-care-for-crswnp-expert-and-patient-insights/36695/Chronic rhinosinusitis with nasal polyps (CRSwNP) presents a large burden on more than 3 million patients with the conditions — especially when intertwined with asthma and allergy. Join our discussion between patients with CRSwNP and leading experts in ENT, allergy, and pulmonary medicine as they:Chairperson’s Perspective: Evidence-Informed Clinical Decision-Making in HER2-Overexpressed and TROP2-Targeted NSCLC
https://reachmd.com/programs/cme/chairpersons-perspective-evidence-informed-clinical-decision-making-in-her2-overexpressed-and-trop2-targeted-nsclc/39894/Study HER2 IHC testing, efficacy, and NCCN guidance supporting ADC sequencing for HER2-overexpressed NSCLC and TROP2-directed ADCs for EGFR-TKI–resistant NSCLC.Incorporating Guideline-Recommended Targeted Therapies Into R/R AML Management
https://reachmd.com/programs/cme/incorporating-guideline-recommended-targeted-therapies-into-rr-aml-management/36181/Explore advances in AML that integrate risk stratification, molecular profiling, and menin-targeted therapies to optimize care and improve outcomes.How Ichthyosis Can Affect Mental Health—And How We Can Address It
https://reachmd.com/programs/practical-dermatology/how-ichthyosis-can-affect-mental-health-and-how-we-can-address-it/24029/As a rare condition, ichthyosis can bring additional burdens upon patients and caregivers alike.